Papersprediabetes8492491

Healthful and unhealthful plant-based diets and risk of breast cancer in U.S. women: results from the Nurses’ Health Studies

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 01-10-2021 · 8492491 on PMC →
Entities in this paper
Healthful plant-based diet adherence Unhealthful plant-based diet adherence Plant-Based Diet Diet high intake - oily fish Breast Cancer ER-negative breast cancer Invasive breast implant sizer ER-negative invasive breast cancer incidence

Extracted findings (5)

Greater adherence to a healthful plant-based diet (hPDI) was associated with a modest but significant reduction in total invasive breast cancer risk, independent of weight change, total carotenoid int

Effect: improvement; HR Q5 vs Q1 0.89; CI: 95% CI 0.83, 0.94

Size: HR Q5 vs Q1 0.89 CI: 95% CI 0.83, 0.94

Greater adherence to a healthful plant-based diet was associated with a 23% lower risk of ER-negative breast cancer, the strongest inverse association observed among all subtypes, robust to adjustment

Effect: improvement; HR Q5 vs Q1 0.77; CI: 95% CI 0.65, 0.90

Size: HR Q5 vs Q1 0.77 CI: 95% CI 0.65, 0.90

Greater adherence to an unhealthful plant-based diet was associated with a 28% higher risk of ER-negative breast cancer, though this association was attenuated after adjustment for dietary fiber or to

Effect: decline; HR Q5 vs Q1 1.28; CI: 95% CI 1.08, 1.51

Size: HR Q5 vs Q1 1.28 CI: 95% CI 1.08, 1.51
Plant-Based Diet
improvement

Greater adherence to an overall plant-based diet index was associated with an 11% lower risk of invasive breast cancer, though the association was modestly attenuated after adjusting for weight change

Effect: improvement; HR Q5 vs Q1 0.89; CI: 95% CI 0.84, 0.95

Size: HR Q5 vs Q1 0.89 CI: 95% CI 0.84, 0.95

In ancillary analysis entering the three food categories together, the highest vs lowest quintile of healthy plant-based food intake was associated with a 26% lower risk of ER-negative breast cancer.

Effect: improvement; HR 0.74; CI: 95% CI 0.61, 0.88

Size: HR 0.74 CI: 95% CI 0.61, 0.88